NEW YORK – An international team of researchers has found that assessing T cells in primary melanomas can help clinicians predict metastatic recurrence in patients whose cancerous lesions have been surgically resected.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.